Cys-loop receptors are neurotransmitter-gated ion channels that are essential mediators of fast chemical neurotransmission and are associated with a large number of neurological diseases and disorders, as well as parasitic infections [1] [2] [3] [4] . Members of this ion channel superfamily mediate excitatory or inhibitory neurotransmission depending on their ligand and ion selectivity. Structural information for Cys-loop receptors comes from several sources including electron microscopic studies of the nicotinic acetylcholine receptor 5 , highresolution X-ray structures of extracellular domains 6 and X-ray structures of bacterial orthologues [7] [8] [9] [10] . In 2011 our group published structures of the Caenorhabditis elegans glutamate-gated chloride channel (GluCl) in complex with the allosteric partial agonist ivermectin, which provided insights into the structure of a possibly open state of a eukaryotic Cys-loop receptor, the basis for anion selectivity and channel block, and the mechanism by which ivermectin and related molecules stabilize the open state and potentiate neurotransmitter binding 11 . However, there remain unanswered questions about the mechanism of channel opening and closing, the location and nature of the shut ion channel gate, the transitions between the closed/ resting, open/activated and closed/desensitized states, and the mechanism by which conformational changes are coupled between the extracellular, orthosteric agonist binding domain and the transmembrane, ion channel domain. Here we present two conformationally distinct structures of C. elegans GluCl in the absence of ivermectin. Structural comparisons reveal a quaternary activation mechanism arising from rigid-body movements between the extracellular and transmembrane domains and a mechanism for modulation of the receptor by phospholipids.
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We obtained three-dimensional crystals of GluCl in the absence of ivermectin by supplementing the previously characterized receptorFab complex 11 with 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine (POPC) and either setting up crystallizations immediately or after a 4-week incubation, which yielded an apo state or a POPC-bound conformation, respectively. The structures of GluCl in an apo state or in complex with POPC show a solvent-accessible pathway from the outermost region of the extracellular domain, through the vase-shaped extracellular vestibule, to the transmembrane ion channel pore (Fig. 1a, b , Extended Data Fig. 1 and Extended Data Table 1 ). The ion channel pore is lined by the M2 transmembrane helices, with Pro 243 and Leu 254 occupying key sites at the cytoplasmic and middle portion of the ion channel. In the POPC complex, we visualized lipid molecules bound between subunits, near the extracellular side of the transmembrane domain, with their head groups wedged between the M1 and M3 helices of adjacent subunits ( Fig. 1b and Extended Data Fig. 1c, d ).
In the apo state the M2 helices are nearly parallel to the pore axis with three narrow regions at Pro 243, Thr 247 and Leu 254 (Fig. 1c) . The pore is most constricted at Leu 254 (Leu 99 on the M2, pore-lining helix), with the hydrophobic side chain of the leucine residue restricting the pore radius to ,1.4 Å , too small for the conduction of chloride ions, suggesting that Leu 254 forms the shut gate of the ion channel pore (Extended Data Fig. 2 ) 12, 13 . Previous observations that mutation of Leu 99 perturbs ion channel gating are in harmony with the hypothesis that Leu 99 has an important role in channel function [14] [15] [16] . We suggest that Figure 1 | Apo and POPC-bound GluCl. a, Sagittal slice along the pore axis of the apo GluCl structure showing the solvent-accessible surface and underlying secondary structure. b, Sagittal slice through the pore of GluCl in complex with POPC, similar to panel a. Atoms of the POPC head group are visible through a fenestration between adjacent subunits. c, Solvent contours of the transmembrane pore of the apo GluCl pore showing the M2 helices of subunits P and R and the side chains of pore-lining residues, numbered according to protein sequence and position in the M2 helix. Small blue spheres define a radius .2.8 Å and cyan spheres represent a radius of 1.4-2.8 Å . d, Contours of the POPC-bound pore, similar to panel c. e, Illustration of the pore radii as a function of distance along the pore axis for apo, POPC-and ivermectinbound GluCl, along with the open and closed states of GLIC (Protein Data Bank accessions 3EAM and 4NPQ). Pore radii in panels c-e were calculated using the computer program Hole. IVM, ivermectin.
this apo structure of GluCl defines the closed/resting state of this eukaryotic Cys-loop receptor.
In the POPC-bound structure, the ion channel pore is also straight, yet wider than in the apo state, with a constriction at Leu 254 yielding a pore radius of ,2.4 Å (Fig. 1d) , similar in size to the narrow region of the pore in the ivermectin-bound state. Comparisons of the pore radii of the apo and ivermectin-bound states of GluCl with ELIC (Erwinia chrysanthemi ligand-gated ion channel) and GLIC (Gloeobacter violaceus ligand-gated ion channel) [7] [8] [9] [10] show how the dimensions are remarkably similar near the cytoplasmic region of the pore, yet diverge substantially at the extracellular entrance ( Fig. 1e and Extended Data Fig. 3 ). While the position of the shut gate in the 'closed' GLIC structure is similar to that of apo GluCl, the pore of GLIC is narrower in comparison to the pore of GluCl in the area extracellular to the gate. Additional studies are required to define the ion-conducting properties of both the ivermectinand POPC-bound states of GluCl.
Inspection of electron density maps derived from GluCl crystals grown in the presence of POPC after an ,4-week incubation with lipid revealed prominent densities located between transmembrane segments M1 and M3 of adjacent subunits in 8 of the 10 subunit interfaces in the asymmetric unit (Extended Data Fig. 4a, b) . We modelled these densities as POPC molecules with the phosphocholine head group pointing towards the centre of the pore and the two alkyl tails located on the periphery of the transmembrane domain (Fig. 2a, b and Extended Data Fig. 4a, b) . The region occupied by POPC molecules overlaps with the ivermectin site derived from the GluCl-ivermectin complex (Fig. 2b) 
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, a binding pocket that recent molecular dynamics simulations also identified as an intersubunit crevice transiently occupied by, on average, four lipid molecules per pentamer 17 . We screened several lipids in binding assays, finding that 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphoserine (POPS) competes for ivermectin binding with an inhibition constant (K i ) of ,167 mM ( Fig. 2c and Extended Data Fig. 4c, e) . Unfortunately POPS, while binding strongly, does not yield well-diffracting crystals whereas POPC binds weakly and does not measurably compete for ivermectin binding. We therefore used POPS in binding experiments and POPC in the structural studies. POPS potentiates glutamate binding (Fig. 2d) Data Fig. 4d ). Thus, ivermectin or lipids can occupy the intersubunit crevice within the membrane-spanning region of the receptor and potentiate neurotransmitter binding, providing insight into the long-standing observation of small molecule and lipid modulation of agonist binding in Cys-loop receptors 18, 19 . Superpositions of individual subunits from the apo, POPC-and ivermectin-bound states demonstrate that the extracellular and transmembrane domains move largely as rigid bodies, undergoing movements relative to one another (Extended Data Fig. 5 ). Thus, superposition of the extracellular domain from a single subunit of the apo and ivermectinbound structures shows that, during activation by ivermectin, the transmembrane domain undergoes a screw-axis-like movement, rotating around an axis tipped about 40u off the pore axis and shifting towards the extracellular side of the membrane by ,4.5 Å . Transition from the apo to the ivermectin-bound state thereby involves tilting of the porelining M2 helix by ,8u 'away' from the ion channel, which relieves the occlusion of the pore by Leu 254 (Fig. 3a and Extended Data Fig. 6 ).
The conformations stabilized by ivermectin and by POPC are markedly different. In comparing the apo and POPC-bound states, the transmembrane domain undergoes a rotation about an axis approximately parallel to the pore, which in turn gives rise to a displacement by ,3 Å 'away' from the pore axis in the plane of the membrane. Together these movements lead to an expansion of the ion channel pore while the M2 helices remain oriented parallel to the pore axis (Fig. 3b) . A comparison of the ivermectin-and POPC-bound states shows a large relative movement of the extracellular and transmembrane domains, with the M2 helix undergoing a tilt by ,8.7u and a translational movement of ,6 Å (Fig. 3c) . Participating in these relative movements of the extracellular and transmembrane domains is the namesake Cys-loop, which is cradled in a concave depression on 'top' of the transmembrane helices, stabilized by interactions that include the b10-M1 covalent connection and the interface between the b1-b2 and M2-M3 loops (Fig. 3a-c ) 5, 20 . Superpositions of the transmembrane domains of the apo, POPCand ivermectin-bound structures further illustrate the relative conformational changes between the extracellular and transmembrane domains ( Fig. 3d and Extended Data Fig. 6 ). Here we observe mainly two movements: the upper part of the extracellular domain, as marked by the a1 helix, twists around the pore axis, and the lower part, as exemplified by the b8 strand, tilts towards the centre of the pore. For both movements, displacements are largest for the transition to the ivermectin-bound state. Loop C does not close the neurotransmitter binding site by an independent motion but closure is rather a consequence of the rigidbody twist of the extracellular domain of each subunit. While the observed closure of loop C is mechanistically distinct from that observed in AChBP (refs 21, 22) , it is consistent with biochemical studies of nicotinic receptors wherein agonist binding results in protection of the tip of loop C from reducing reagents 23 .
To visualize the conformational changes associated with ivermectin binding, we superimposed the transmembrane domains of the (2)-subunits for the apo and ivermectin states (Extended Data Fig. 7 ). Inspection of the transmembrane helices in the (1)-subunit shows that in the apo state the space between the M3 and M1 helices of the (1)-and the (2)-subunits is 'collapsed' (Fig. 3e) . When ivermectin inserts into this site, helices M1-M4 undergo an anticlockwise rotation of ,10u relative to the pore axis, 'splaying open' the intersubunit interface. This movement increases the a-carbon distance between Leu 218 (M1) and Gly 281 (M3), the latter of which is crucial for ivermectin sensitivity 24 , from ,6.9 Å in the apo state to ,9.3 Å in the ivermectin complex. The M2-M3 loop not only participates in direct contacts with ivermectin via Ile 273 (ref. 11), but it also connects helix M3 of the ivermectin site 
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with helix M2 of the ion channel pore, thus providing a direct coupling for the binding of ivermectin with the tilting of the M2 helix ,4 Å away from the five-fold axis and opening of the pore.
In comparison to ivermectin, the longer POPC head group inserts deeply into the intersubunit crevice. Thus, analysis of the POPC complex relative to the apo state shows that transmembrane segments of the (1)-subunit undergo a greater displacement in comparison to the ivermectin complex, with the (1) transmembrane bundle moving ,5.7 Å towards the ion channel pore ( Fig. 3f and Extended Data Fig. 7 ). Nevertheless, the separation between subunits is similar to the ivermectin complex, as measured by the 9.4 Å distance between the a-carbons of residues Leu 218 (M1; (2)-subunit) and Gly 281 (M3; (1)-subunit).
A remarkable plasticity of the transmembrane domains is demonstrated by comparison of the ivermectin and POPC complexes (Extended Data Fig. 7) . Here, superposition of the transmembrane regions of the (2)-subunit shows that the transmembrane bundle of the (1)-subunit from the POPC complex moves ,8.8 Å 'away' from the ion channel pore. This shift of nearly the diameter of an a-helix results in the (1) M3 helix occupying the position of the (1) M2 helix in the ivermectin complex, thus showing how, in these two complexes, M2 replaces M3 at the interface with M2 of the (2)-subunit (Fig. 3g) .
To analyse the changes at the orthosteric glutamate binding site we superimposed the extracellular domains of the (1)-subunit, a facet of the pocket that harbours multiple elements of the agonist binding site, including an aromatic box closed by loop C (refs 6, 11, 21) . Following this superposition, we see that the b-strands on the (2)-subunit shift closer to the (1)-subunit in the POPC and ivermectin complexes, with the largest shift seen in the ivermectin-bound state (Fig. 3h) . These shifts close the binding pocket, moving key residues towards the (1)-subunit and thereby, we speculate, strengthening neurotransmitter binding. Consistent with this notion is our earlier observation that, like ivermectin, POPC binding potentiates binding of glutamate. Indeed, in the ivermectinbound conformation the a-carbon atoms of Ser 121 and Arg 56 move by 2.2 Å and 2.5 Å , respectively, from their positions in the apo state (Fig. 3h) . The positions of neurotransmitter-binding residues in the POPC complex are intermediate between their respective positions in the apo and ivermectin complex, thus providing an explanation of how lipids, such as POPS, might potentiate neurotransmitter binding.
The extracellular and transmembrane domains are covalently connected by the b10-M1 linker yet they also interact via contacts between the b1-b2 loop and the M2-M3 loop as well as contacts between the Cys-loop and the extracellular ends of the transmembrane helices. Indeed, the M2-M3 linker, the b1-b2 loop and the Cys-loop are 'hotspots' of non-covalent bonds and steric interactions that have been extensively studied 20, 25, 26 . During channel opening, as defined by the transition from the apo to the ivermectin-bound state, the M2-M3 loop shifts by more than 5 Å away from the ion channel pore, as visualized by the movement of Pro 268 of the M2-M3 loop passing beneath Val 45 on the b1-b2 LETTER RESEARCH loop (Fig. 4a, b) . In the ivermectin-bound conformation, Val 45 is lodged against Pro 268, thus providing a steric block on the M2-M3 loop and, in turn, stabilizing the M2 and M3 helices and the entire transmembrane domain in an open pore conformation 27 . Furthermore, Pro 268 is strictly conserved throughout the family of Cys-loop receptors, and mutations of this residue, as well as others nearby, have profound effects on the channel gating and desensitization behaviour 1, 28 . The extracellular end of the M3 helix interacts with the Cys-loop via a hydrogen bond between the carbonyl oxygens of Gln 135 and Pro 138 and the amide nitrogens of Lys 274 and Ala 275, respectively (Fig. 4c) . The Cys-loop itself is also stabilized by a backbone hydrogen bond between Tyr 136 and Met 139 and is coupled to the extracellular end of the M1 helix by a hydrogen bond between backbone atoms of Asp 140 and Arg 211, a salt bridge between the side chains of Arg 211 and Asp 140 and the carbonyl oxygen of Tyr 137, as well as interactions between strands b7 and b10 (Fig. 4c, d ) 29 . All these interactions remain intact in the three GluCl conformations (Extended Data Fig. 8 ). Through this route movements of the M1 helix can be directly transmitted to the M3 helix in the same subunit. Additionally, changes in the transmembrane domain can be transmitted to the (1) side of the ligand binding site via the b7 and b10 strands. Nevertheless, we do not find evidence for a direct coupling between the b10-M1 linker and b1-b2 loop as in the bacterial orthologues 7 and in the acetylcholine receptor 30 . Because the charged amino acids in the b1-b2 loop are replaced by Val 44 in GluCl, no salt bridge with Arg 211 can be formed (Fig. 4d) .
Global superpositions of pentamers from the apo, ivermectin and POPC-bound states illustrate quaternary conformational differences (Fig. 5, Extended Data Fig. 9 and Supplementary Movies 1 and 2 ). In the apo state the extracellular domains are separated by ,43 Å as measured at Thr 11 in helix 1 in two opposing subunits. The M2 helices are straight and oriented perpendicular to the plane of the membrane with distances of 12.6 Å at Ser 265 (pore apex) and 9.8 Å at Pro 243 (pore base) and the pore is occluded by the side chains of Leu 254. In the ivermectinand POPC-bound states the upper parts of the extracellular domains tilt towards the pore in a motion resembling the closure of a blossom. The distances at helix 1 shrink to 36.3 Å in the ivermectin-bound state and to 38.2 Å in the POPC-bound conformation (Extended Data Fig. 9a-c) . The changes in the transmembrane domain are markedly different between the ivermectin-and the lipid-bound conformations. In the former case the M2 helices tilt away from the five-fold axis and the distance at the pore apex increases to 18.9 Å while it remains nearly constant at the intracellular side. Helices M3 and M4 rotate clockwise around the centre of the helix bundle resulting in an apparent overall clockwise rotation of the whole transmembrane domain of the receptor. In contrast, during the transition from the apo to the POPC-bound state the M2 helices undergo a clockwise twist around the pore axis increasing the distance to 14.3 Å and 14.7 Å (pore apex and base), thus remaining straight. This quaternary structural change leads to an iris-like opening of the pore and causes M1 and M3 to be displaced in an anticlockwise rotation with little displacement of M4 (Extended Data Fig. 9d-f) .
We hypothesize that the structures of GluCl in the apo and ivermectinbound forms represent the closed/resting state and a potentially open/ activated state of a eukaryotic Cys-loop receptor, respectively, showing how the shut ion channel gate is defined by a hydrophobic belt of five leucine residues and how the possible opening of the ion channel pore involves the outward tilting of approximately straight M2 transmembrane helices and the inward contraction of the extracellular domain (Fig. 5a-c) . Accompanying these quaternary changes is a 'bend/twist' of each subunit at the junction of the extracellular-transmembrane domain boundary, where the namesake Cys-loop acts like a ball in the socket of the extracellular end of the transmembrane domain, interactions further stabilized by the b10-M1 connection and by interactions between the M2-M3 and b1-b2 loops. The GluCl-POPC complex demonstrates how lipids can allosterically modulate Cys-loop receptor function, inducing an expanded, open-like conformation of the transmembrane domain and potentiating agonist binding. Taken together, these studies provide motivation for future experiments and insight into the gating, modulation and structural plasticity of eukaryotic Cys-loop receptors.
Online Content Methods, along with any additional Extended Data display items and Source Data, are available in the online version of the paper; references unique to these sections appear only in the online paper. 
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METHODS
GluCl construct, expression, purification and complex with Fab. The GluCl cryst protein construct, a version of the C. elegans GluCla ion channel (GenBank accession code AAA50785.1) with truncated termini and the M3-M4 loop replaced by a three-amino-acid linker, the method of its expression in baculovirus-infected Sf9 insect cells and the preparation of the anti-GluCl Fab were performed as previously described 11 . The GluCl pentamer was extracted from membranes with n-dodecylb-D-maltopyranoside (C 12 M), purified by Co 21 metal ion affinity chromatography, combined with the Fab and further purified by size exclusion chromatography in a buffer composed of 20 mM Tris (pH 7.4), 150 mM NaCl and 1 mM C 12 M. Fractions containing the receptor-Fab complex were pooled and concentrated to 1-2 mg ml 21 . Crystallization and cryoprotection. Before crystallization the GluCl-Fab complex was slowly stirred in the presence of 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine (POPC) lipid (2.6 mg ml 21 ) and additional C 12 M detergent (13 mg ml 21 ) at 4 uC for 14 h (ref. 31) . After incubation of the protein with lipid, the mixture was clarified by centrifugation before crystallization. Crystals of the of GluCl cryst -Fab complex were grown by hanging-drop vapour diffusion at 4 uC using a reservoir solution composed of 50 mM sodium citrate pH 5.5, 35-36% pentaerythritol propoxylate (5/4 PO/OH), and 100 mM potassium chloride. The crystals were directly flash frozen in liquid nitrogen. Crystals of the apo GluCl-Fab complex were produced by immediately setting up crystallization drops after treatment of the complex with lipid and detergent whereas crystals of the POPC complex were grown after the GluCl-Fab-lipid complex had been stored at 4 uC for 4 weeks. Data collection. Diffraction data sets were collected at beamline 24-ID-C at the Advanced Photon Source synchrotron, Argonne National Laboratory, using crystal pins mounted on a mini-Kappa goniometer. Diffraction data were measured from different regions on single crystals using in-house data collection strategy software. The best-ordered crystals for the apo data set have a diffraction limit of 3.6 Å and the crystals for the apo-POPC complex diffracted to 3.2 Å resolution (Extended Data  Table 1 ). Diffraction data sets were indexed, integrated and scaled using HKL2000 32 or XDS 33 software together with the microdiffraction assembly method 34 . Structure determination. The structures were initially solved by molecular replacement using Phaser 35 with the pentameric GluCl cryst -Fab complex (Protein Data Bank 3RHW) 11 as a search probe, yielding a robust solution with two pentameric complexes in the asymmetric unit of a C2 unit cell. Electron density maps were improved by density modification that included solvent flattening and averaging that exploited the ten-fold non-crystallographic symmetry (NCS). Phases were extended from 6 Å to the resolution of the data sets without phase combination using the computer program DM 36 . The model was refined by a rigid body fit of the transmembrane domain in PHENIX 37 and Coot 38 applying ten-fold NCS operations to the receptor chains. As with the original structure of the GluCl-Fab complex 11 , the constant domains of the Fabs did not obey the ten-fold symmetry and were not constrained to the ten-fold NCS. Models were improved by iterative rounds of restrained reciprocal space refinement using PHENIX and manual adjustment in Coot guided by simulated annealing composite omit electron density maps. In the final stages of refinement, we defined four separate regions of the apo complex that were each allowed independent ten-fold NCS axes: GluCl cryst (residues 1-300), GluCl cryst residues 314-340 or 342), heavy chain Fab variable domains (residues 1-120), and light chain Fab variable domains (residues 1-108). The POPC complex was refined with three NCS groups: GluCl cryst (residues 1-342), heavy chain Fab variable domains (residues 1-120), and light chain Fab variable domains (residues 1-108). Isotropic B factors with one group per residue and translation/libration/screw (TLS) parameters 39 were also refined; the 30 TLS groups comprised 10 receptor subunits, 10 Fab variable domains, and 10 Fab constant domains. Model quality was assessed using Molprobity 40 . After the initial structure determination and refinement the original diffraction data sets were reprocessed by applying the microdiffraction assembly method together with XDS which increased the useful resolution of the diffraction data by 0.2-0.3 Å . Five per cent of randomly selected reflections were set aside before refinement for calculation of R free . Structure refinement was carried out by restrained reciprocal space refinement in PHENIX and manual building into the resulting F o 2 F c difference maps in Coot. The final model of the apo structure contains two GluCl cryst pentamers that include residues 1-102 and 106-340, a single N-linked carbohydrate attached to Asn 185, 10 Fab molecules (residues 1-221 or 224 for the heavy chains; residues 1-211 or 215 for the light chains), five detergent molecules, two chloride ions in one pentamer and a citrate molecule in one of the pentamers. Residues 103-105 lacked clear electron density in F o 2 F c maps and hence were omitted from the final model. The final model of the POPC complex also contains two GluCl cryst pentamers that include residues 1-340 or 342, an N-linked carbohydrate at Asn 185 at 9 of the 10 subunits, 10 Fab molecules (residues 1-222 or 224 for the heavy chains; residues 1-210 or 215 for the light chains), seven POPC lipid molecules and one glycerol molecule lodged between receptor subunits, four detergent molecules and a chloride ion in each pentamer. In both structures, proline 138 in the Cys-loop was modelled in the cis conformation, consistent with findings from the higher resolution structures of a Cys-loop receptor bacterial orthologue 41 . The electron density for the conformation of this proline is ambiguous, and thus one should not draw a mechanistic conclusion comparing the cis conformation in this study with the trans conformation in the earlier GluCl structures. Molecular graphics images were made using PyMOL 42 . Pore dimensions were analysed using HOLE software 43 . Domain movements within a single GluCl subunit were investigated with DynDom1D (http://fizz.cmp.uea.ac.uk/dyndom/) 44 . Morphs between structures were calculated in UCSF Chimera 45 .
Radioligand binding experiments. The dissociation constant for ivermectin was measured by saturation ligand binding assays using His-tagged GluCl cryst , [24, H]-ivermectin-B1a and the scintillation proximity assay (SPA) 46 together with YSi copper beads. Binding reactions were performed in 20 mM Tris pH 7.4, 150 mM NaCl (TBS), 10 mM C 12 M and contained 10 nM binding sites and 1 mg ml 21 SPA beads. Background binding was determined in the presence of 100 mM cold ivermectin. Counts were stable after 24 h.
Competition binding experiments with lipids were carried out using 100 nM [ pentamer from the extracellular side together with contours from an 'omit' style electron density map computed using F o 2 F c coefficients and phases from coordinates where atoms associated with POPC molecules were omitted from the structure factor computation. The electron density map is shown as blue mesh and is contoured at 1.5s. Prominent electron density features are visible between transmembrane domains of adjacent subunits although the strength and continuity of the density varies from subunit to subunit. b, Close-up view of one putative electron density feature with POPC drawn as stick representation and viewed in the plane of the membrane. c, Radioligand competition binding experiment using GluCl cryst , [ a-c, Views of the transmembrane domain seen from the extracellular side after superposition of the extracellular domain (residues 1-211) for the apo (blue) and the ivermectin-bound (grey) complex (a), for the apo and POPC-bound (orange) complexes (b) and for the POPC-and ivermectin-bound structures (c). Panels d-f illustrate relative conformational changes within a subunit when the transmembrane domains are superimposed, using residues 212-342 and the same colour coding as in panels a-c. g-i, Views from the extracellular side onto the extracellular domain after superimposing the transmembrane domain of the apo and ivermectin-bound conformation (g), the apo and POPC-bound structures (h) and the POPC-and ivermectin-bound complexes (i). The tilt and twist axes between transmembrane domain and extracellular domain are indicated by arrows as marked in the figure panels. LETTER RESEARCH
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